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Skeletal muscle can be engineered by converting dermal precursors into muscle progenitors and differentiated
myocytes. However, the efficiency of muscle development remains relatively low and it is currently unclear if
this is due to poor characterization of the myogenic precursors, the protocols used for cell differentiation, or a
combination of both. In this study, we characterized myogenic precursors present in murine dermospheres, and
evaluated mature myotubes grown in a novel three-dimensional culture system. After 5–7 days of differentia-
tion, we observed isolated, twitching myotubes followed by spontaneous contractions of the entire tissue-
engineered muscle construct on an extracellular matrix (ECM). In vitro engineered myofibers expressed canonical
muscle markers and exhibited a skeletal (not cardiac) muscle ultrastructure, with numerous striations and the
presence of aligned, enlarged mitochondria, intertwined with sarcoplasmic reticula (SR). Engineered myofibers
exhibited Na + - and Ca2 + -dependent inward currents upon acetylcholine (ACh) stimulation and tetrodotoxin-
sensitive spontaneous action potentials. Moreover, ACh, nicotine, and caffeine elicited cytosolic Ca2 + transients;
fiber contractions coupled to these Ca2 + transients suggest that Ca2 + entry is activating calcium-induced calcium
release from the SR. Blockade by d-tubocurarine of ACh-elicited inward currents and Ca2 + transients suggests
nicotinic receptor involvement. Interestingly, after 1 month, engineered muscle constructs showed progressive
degradation of the myofibers concomitant with fatty infiltration, paralleling the natural course of muscular
degeneration. We conclude that mature myofibers may be differentiated on the ECM from myogenic precursor
cells present in murine dermospheres, in an in vitro system that mimics some characteristics found in aging and
muscular degeneration.
Introduction
Muscle is one of the major tissues by weight in thebody, confering adaptive functions of great value such
as external and internal mobility (the latter being important
for cardiac muscle and internal cavity and vessel contrac-
tion). Energetically, it is a high consumption organ, and due
to its demanding physiology throughout a normal lifespan,
skeletal muscle requires lifelong regenerative capacities that
are provided by a resident stem cell pool, known as satellite
cells.1 However, age-associated trauma and immobility may
produce sarcopenia, an indirect cause of mobility problems
in older people.2 In particular, the frail elderly are typically
most exposed to falls, which have a major economic impact
on public health systems worldwide. On the other hand,
genetic or toxic injuries may also cause transient or
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progressive muscular degeneration. Muscular dystrophies
encompass a heterogeneous family of genetic conditions that
generate physical disability and have a devastating impact
on patients and relatives.3 In both scenarios, the study of
muscular function has been mostly based on human muscle
biopsies (taken for diagnostic purposes) and analyses of
murine models, both in healthy and genetically modified
animals that recapitulate myopathic diseases. However,
muscle biopsies are progressively being replaced in clinical
practice by less invasive diagnostic methods, such as diag-
nostic radiology4 and subsequent molecular profiling,5
which have quickly become the clinical gold standard.6 On
the other hand, animal models do not always reflect all as-
pects of human pathology. For these reasons, the ability to
generate a human cell-based, tissue-engineered system to
study muscle physiology and pathology constitutes a major
scientific goal.
Embryonic and induced pluripotent stem (ES/iPS) cell-
derived human myogenic cell cultures are already being
used successfully as preclinical models of muscular dis-
ease.7,8 However, ES/iPS cell-based muscle modeling sys-
tems are expensive and time-consuming to develop, and as
such, could be complemented by a simpler and more cost-
effective adult stem cell-based culture model. Moreover,
two-dimensional cellular models do not reflect many aspects
of muscular physiology,9 and it is thus desirable to engineer
three-dimensional (3D) tissue constructs that more properly
reflect muscle properties in vivo, such as contractility seen on
constructs engineered on collagen gels.10 In this sense, and
although a number of 3D tissue-engineered muscle con-
structs are available,11 it is currently acknowledged that a
suitable cell source (other than satellite cells, which grow
poorly in vitro) and improved myogenic differentiation pro-
tocols, are urgently needed.12 It is therefore apparent that an
alternative muscle progenitor cell source would be desirable
to develop tissue-engineered models, which should have an
easier (less invasive) access than muscle. Ideally, and to treat
adult onset muscular diseases, the cell source should be
available in adults.
While several alternative cell sources are being consid-
ered,13 skin-derived precursor cells (SKPs) meet both these
requirements. These dermal precursors may be isolated via
minimally invasive procedures.14,15 Furthermore, derivation
of skeletal muscle has been achieved from murine SKP cul-
tures, although with relatively low efficiency compared to
other myogenic precursor cells.16,17 In this article, by making
use of a novel 3D support composed of a mixture of Ma-
trigel-like extracellular matrix (ECM), hyaluronic acid, and
netrins, we improve the differentiation of murine dermal
precursors to achieve levels of myogenicity similar to those
of muscle satellite cells on similar supports.18,19 Future work
will pursue derivation of similar engineered muscle con-
structs from human dermis-derived cells.
Materials and Methods
Animals
Eight-week-old female CD1 mice were used in accordance
to the guidelines and approval provided by the Biodonostia
Animal Care Committee (San Sebastian, Spain) in accordance
with the European Directive 2010/63/EU and the guidelines
established by the National Council on Animal Care.
Isolation and proliferation of dermal precursor cells
Precursor cells were isolated from back skin as de-
scribed.20 For primary dermosphere expansion, a prolifera-
tion medium [Neurobasal A (Gibco) supplemented with
2% B27 (Gibco), 1% L-glutamine 200mM (Sigma-Aldrich),
and 1% penicillin/streptomycin] was supplemented every 2
days with a 2% low serum growth supplement (LSGS, Gib-
co), 40 ng/mL of the epidermal growth factor (EGF; R&D),
and 80 ng/mL of the basic fibroblast growth factor (FGF2;
R&D).
Preparation of ECM and poly-L-ornithine-coated
subtrates
ECM-coated glass coverslips were prepared as de-
scribed,21 that is, incubated with a solution of Cultrex
basement membrane extract, hyaluronan, and netrins in
phosphate-buffered saline (PBS). To compare ECM-based
culture with a previously published protocol,16 a 0.01% so-
lution of poly-L-ornithine in distilled water (Sigma-Aldrich)
was used to coat coverslips, followed by a PBS wash and a
drying period of 1 h under laminar flow.
Skeletal muscle induction and contractile myotube
video recordings
For muscle induction, primary dermospheres after 7 days
of proliferation were gently disaggregated with a 0.25%
trypsin-EDTA solution (Sigma-Aldrich) and resuspended in
the differentiation medium [the proliferation medium with-
out added growth factors plus 10% fetal bovine serum (FBS;
ATCC)], before plating onto coated coverslips at a density of
75,000 cells/cm2. Every 2 days, half of the culture volume
was replaced with a fresh medium. At day 5–7 of differen-
tiation, myoblast fusion and contractile activity were ob-
served. Bright field microscopic images of cultures as well as
video recordings of twitching myotubes were taken by using
a Nikon D90 digital camera coupled to a Nikon Eclipse
TS100 microscope.
Skin histology
Murine dorsal skin fragments of approximately 0.5 cm2
were excised, embedded in a Tissue-Tek O.C.T. compound
(Sakura), and immediately frozen in isopentane (Merck)
cooled in liquid nitrogen. Seven micron transverse sections
were processed and stained with hematoxylin–eosin (H&E).22
Immunofluorescence and microscopy
Cells were washed with PBS (pH 7.2, Ca2+ and Mg2+ free,
Gibco) and fixed in 4% paraformaldehyde (PFA; Electron Mi-
croscopy Sciences) for 10min at room temperature (RT). Cells
were further washed twice in PBS, and permeabilized/blocked
by using 0.3% Triton X-100 in PBS (PBST) plus 5% normal
donkey serum (Sigma-Aldrich) for 1h at RT. Cells were incu-
batedwith the appropriate primary antibodydiluted in PBST for
2h at RT (detailed in Supplementary data; Supplementary Data
available online at www.liebertpub.com/tea). After three PBS
washes (5min each), fixed cellswere incubated for 1h at RTwith
a donkey anti-mouse Alexa Fluor 488 secondary antibody
(Invitrogen; 1:500) diluted inPBST. Beforemounting inMowiol
(Fluka), cellswere counterstainedwith 10mg/mLHoechst 33258
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(Sigma-Aldrich) for 5min at RT and washed with distilled wa-
ter. Fluorescence imageswere obtained by using aNikonEclipse
80i microscope coupled to Nikon Digital Sight and analyzed
with Nikon NIS-Elements Advance Research software. For
quantitative assessment, at least nine different fields out of three
independent experiments were quantified. To estimate the total
cell number in each photograph, the number of nuclei stained by
Hoechst was counted and the percentage of cells positive for
each immunostain was determined.
Gene expression
Total RNA was extracted from cells by the miRNeasy Mini
kit (Qiagen) and converted into complementary DNA with
the High-Capacity cDNA Reverse Transcription Kit (Applied
Biosystems), according to the manufacturer’s instructions.
Skeletal (gastrocnemius muscle) and cardiac muscle tissues
were also used as positive and negative controls for myo-
genic gene expression analysis, respectively. Real-time
quantitative PCR (RT-qPCR) analysis was carried out using
TaqMan gene expression assays in the 7900 HT Fast Real-
Time PCR System (Applied Biosystems). Each cDNA sample
was amplified in triplicates. The cycling conditions were
95C/10min followed by 40 cycles at 95C/15 s, 60C/1min
in a reaction mixture that contained 1·TaqMan Universal
PCR Master Mix and 1·Assay Mix in a final volume of
10 mL. The relative quantity of the gene target was deter-
mined by the 2DDCt method.23
Western blot
Western blots (WB) were performed as described,24 with
minor modifications. Briefly, skeletal (gastrocnemius) and
cardiac muscle samples were weighed and homogenized in a
TissueLyser mixer-mill disruptor (Qiagen) in 19:1w/v
treatment buffer (0.125M Tris, 4% SDS, 10% glycerol, 0.1M
EDTA, and 5% b-mercaptoethanol). Similarly, 2· 106 cells
were lysed in 100mL of the treatment buffer. About 3 · 105 of
the lysed cells, as well as 5 mg of homogenized samples, were
loaded onto SDS-polyacrylamide gels (Bio-Rad).
Transmission electron microscopy
After fixation in 3.5% glutaraldehyde (Electron Micro-
scopy Sciences), cell cultures were washed in 0.1M PBS (pH
7.4) and treated with 2% osmium tetraoxide (Electron Mi-
croscopy Sciences) in 0.1M PBS (pH 7.4) for 2 h at RT.
Samples were rinsed, dehydrated through increasing ethanol
solutions, and stained in 2% uranyl acetate (Electron Micro-
scopy Sciences) in 70% ethanol. Dehydrated cell cultures
were embedded in araldite (Fluka). Semithin sections (1.5 mm
thick) were cut with a diamond knife and stained with a 1%
Toluidine blue solution (Sigma-Aldrich), re-embedded for
ultrathin (70 nm-thick) sectioning, and examined under a
Tecnai-Spirit Transmission Electron Microscope coupled to a
Morada TEM CCD camera (Soft Imaging System).
Electrophysiological recordings, data acquisition,
and analysis
Electrophysiological properties of twitching myotubes
were investigated after 10–14 days in culture using whole-
cell patch-clamp recording techniques.25 Acetylcholine
(ACh)-induced currents, action potentials, and membrane
potential changes were recorded using the perforated patch
configuration26 under either current or voltage clamp mode,
respectively. Myotube-containing, ECM-coated coverslips
were placed on a recording experimental chamber mounted
on the stage of a Nikon Eclipse T2000 inverted microscope. A
perforated patch was obtained using borosilicate glass
pipettes (Kimble Chase) containing 50–100mg/mL ampho-
tericin B in DMSO (both from Sigma-Aldrich) as a permea-
bilizing agent,27 and a pipette-filling intracellular solution
(freshly prepared every 2 h) containing (in mM) 135 KCl, 10
NaCl, 2 MgCl2, 10 HEPES, and 5 EGTA (pH 7.3 with KOH)
(all from Sigma-Aldrich). To facilitate sealing, the pipette
was first dipped in a beaker containing the internal solution,
and then back-filled with the same solution containing am-
photericin B. Recordings started when access resistance de-
creased below 15MO, which usually occurred within 10min
of sealing. Voltage and current recordings were made with
fire-polished electrodes (resistance 2–5MO when filled with
the intracellular solution) mounted on the headstage of an
EPC-10 patch-clamp amplifier (HEKA Electronic), allowing
cancellation of capacitative transients and compensation of
series resistance. Data were acquired with a sample fre-
quency of 5 kHz. Recordings with leak currents > 100pA or
series resistance > 20MO were discarded. During recording,
myotubes were locally, rapidly, and continuously super-
fused with a Tyrode’s solution containing (in mM) 2 CaCl2,
137 NaCl, 1 MgCl2, 10 glucose, 5.3 KCl, and 10 HEPES/
NaOH (pH 7.3; all from Sigma-Aldrich). The different drugs
(ACh; tetrodotoxin, TTX; d-tubocurarine, dTC) were dis-
solved in the extracellular solutions, which were rapidly
exchanged using electronically driven miniature solenoid
valves coupled to a multibarrel concentration-clamp device,
the common outlet of which was placed within 100 mm of the
cell to be patched. The flow rate was 1mL/min and was
regulated by gravity. Data acquisition was performed using
PULSE programs (HEKA Elektronic) while data analysis was
performed using GraphPad Prism software (version 5.01 for
Windows). All experiments were performed at room tem-
perature (22C–24C). At least three independent experi-
ments were performed to determine the significance of
statistical results.
Measurements of cytosolic Ca2+ concentration
([Ca2+ ]c) changes, data acquisition and analysis
The setup for fluorescence recordings was composed of a
Leica DMI 4000 B inverted light microscope (Leica Micro-
systems) equipped with an oil immersion objective (Leica
40·Plan Apo; numerical aperture 1.25). Before assessment,
cells were incubated for 1 h at 37C in the differentiation
medium containing the calcium probe Fura-2 AM (10mM;
Invitrogen). After Fura-2 loading, coverslips were mounted
in a chamber, and washed/covered with the Tyrode’s solu-
tion (as above). Cells were continuously superfused by
means of a five-way superfusion system at 1mL/min with a
common outlet 0.28-mm tube driven by electrically con-
trolled valves with the Tyrode’s solution with/without
drugs (ACh; nicotine; histamine; caffeine; nifedipine; d-
tubocurarine, dTC; all from Sigma-Aldrich). Fura-2 AM was
excited alternatively at 340 – 10 and 387 – 10 nm using a Leica
Ku¨ber CODIX xenon lamp and emitted fluorescence was
collected through a 540 – 20 nm emission filter and measured
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with an intensified charge coupled device camera (Hama-
matsu camera controller C10600 orca R2). Fluorescence im-
ages were generated at 1-s intervals. Images were digitally
stored and analyzed using LAS AF software (Leica). Data
analysis was carried out on a personal computer, and data
obtained from LAS AF software were exported to Microsoft
Excel tables. Graphs and mathematical analyses were per-
formed using the Graphpad Prism software (version 5.01).
Areas or peak heights were calculated by integrating the
calcium transient over time during the stimulus duration by
means of Origin Pro 8 SR2 software (version 8.0891; Origi-
nLab Corporation). Areas were worked out by the integra-
tion of the input data set by using the trapezoidal rule.
Results are expressed as mean– SEM.
Adipogenic assays
Adipocytes were assessed by Oil Red O staining.28 Cul-
tures were fixed twice in 10% formalin (Sigma-Aldrich) for
10min and 1h at RT, respectively. Fixed cultures were rinsed
sequentially with distilled water and 60% isopropanol (Sig-
ma-Aldrich) for 5min at RT. Once completely dry, cells were
stained with the Oil Red O working solution [60% stock
solution (0.35% Oil Red O (Sigma-Aldrich) in isopropanol)
and 40% distilled water] for 10min at RT. After four con-
secutive washes with distilled water, images were acquired.
Water was then removed and Oil Red O eluted by adding
100% isopropanol for 10min under gentle shaking. Optical
absorbance (OD) at 500 nm was measured using 100%
FIG. 1. Twitching myotubes engineered from dermal precursor cells. (A) Strategy to engineer twitching myotubes from
dermal precursor cells in vitro. Once isolated, dermis-derived cells were expanded as dermospheres in the presence of EGF,
FGF2, and LSGS. After growth factor withdrawal, dermospheres were differentiated into myotubes by seeding on the
extracellular matrix (ECM) and supplementing with serum. (B–E) Histological analyses show the presence of Panniculus
carnosus in murine skin (B, · 100 magnification). After disaggregation, small muscle fragments are present in dermal cultures
(C, · 100), as confirmed in (D) by MyHC immunostaining (nuclei are counterstained with Hoechst; scale bar, 10mm). No
muscle fragments were detected in dermosphere cultures after 7-day proliferation (E, · 100), at the time when spheres were
seeded on ECM. (F, G) A large number of multinucleated (arrows inG), twitching myotubes were observed in culture after 5-
to 7-day differentiation (F,· 100; G, · 200). Color images available online at www.liebertpub.com/tec
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isopropanol as a blank. Three individual experiments were
performed and results were expressed as fold change respect
to the basal condition (24 h after culture, absence of adipo-
cytes). The total concentration of triglycerides was deter-
mined by a coupled enzyme assay (Adipogenesis Assay Kit;
Sigma-Aldrich), which results in a colorimetric (570 nm)
product proportional to the triglycerides present in each
sample.
Assessment of statistical significance
Statistics carried out using GraphPad Prism software. A
one-way analysis of variance (ANOVA) with subsequent
pairwise multiple comparison procedures (Bonferroni’s test)
was used to assess the statistical significance of the results
from immunocytochemistry, RT-qPCR, and adipogenesis
experiments. Unless otherwise stated, statistical analyses of
patch-clamp results were carried out with the one-way
ANOVA test followed by Tukey’s post hoc analyses. Single or
multiple cytosolic Ca2 + concentration ([Ca2 + ]c) changes
were carried out with a one-tailed paired t-test for a confi-
dence interval of 95% or the one-way ANOVA test followed
by Dunnett’s post hoc analyses, respectively. The signs *, **, or
*** represent a statistical significance of p< 0.05, p< 0.01, or
p< 0.001, respectively.
Results
Spontaneously twitching myotubes engineered
from dermis-derived precursors
Once adult dermal precursors that present myogenic po-
tential (both in vitro and in vivo) as previously described16,17
were obtained, two major questions remain unanswered: (1)
what is the source of myogenic precursors within murine
skin, and (2) can we improve the relatively minor differen-
tiation potential shown in vitro by these precursors? To shed
light on both issues, we set up an improved isolation, pro-
liferation, and differentiation protocol for dermis-derived
precursors as depicted in Figure 1A. Of note, primary cell
FIG. 2. Presence of myogenic markers in dermal spheres at the proliferation phase. (A, B)Western blot of myogenic markers
Pax7, MyoD1, Myog, and MyHC (all fibers and embryonic subtypes) using GAPDH as a loading control. Proteins were
detected at day 0 and day 7 of dermosphere culture, as well as in skeletal muscle (SkM) as a positive control. Position of
known size markers is shown to the right of each panel, mouse replicates on the top. (C) Real-time quantitative PCR (RT-
qPCR) of myogenic markers Pax7, MyoD1, Myog, MyH2, and MyH3; as detected at day 0 (empty bars) and day 7 (black bars)
of dermosphere culture. Expression of mRNAs is shown relative to day 0. Mouse replicates are shown on the bottom of each
graph. (D) Detection of myogenic markers MyoD1, Myog, MyHC, TnT, and SERCA1 by immunofluorescence at day 7
dermospheres. A discrete population of dermosphere cells (arrows) expressed myogenic markers in culture (scale bar,
100 mm). Color images available online at www.liebertpub.com/tec
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preparations of disaggregated murine skin include frag-
ments of Panniculus carnosus (PC) muscle (Fig. 1B–D). After 7
days of proliferation, dermis-derived precursors generated
spheres, while muscle fragments were no longer visible in
culture (Fig. 1E). Dermal spheres, enriched in precursor cells,
were then seeded onto ECM-coated coverslips, and multi-
nucleated myotubes were observed after 5–7 days in the
presence of serum (Fig. 1F, G). Interestingly, the engineered
myotubes twitched spontaneously, at times in relative iso-
lation (Supplementary Fig. S1; Supplementary Data are
available online at www.liebertpub.com/tec), but often in a
more widespread and synchronous fashion (Supplementary
Movies SM1–SM3).
To characterize the appearance of myogenic markers in
dermal proliferation culture, expression of Pax7, MyoD1,
Myogenin (Myog), and MyHC were analyzed at day 0 and 7
of sphere culture by Western blot (Fig. 2). As expected (since
muscle fragments were present straight after tissue disag-
gregation), myogenic markers Pax7, MyoD1, Myog, and
MyHC (all fibers) were readily detected at day 0. In contrast,
embryonic MyHC, a marker of myogenic precursors and
nascent myotubes, was absent. Interestingly, expression of all
these markers diminished (to levels barely detectable by
Western blot) by day 7when dermosphereswere already fully
formed. The only exception being embryonic MyHC that was
clearly detected at this stage (Fig. 2A, B). These data thus
FIG. 3. Engineered muscle is composed of skeletal (not cardiac) myotubes. (A–D) By immunofluorescence, myotubes
grown for 7 days on the ECM showed high nuclear expression of myogenin (A, B, arrows; note that other nonmyogenic cells
are present in culture, but no expression of myogenin is detected in their nuclei, arrowheads) and sarcoplasmic MyHC (C, D).
Striated patterns (arrows), indicative of contractile function, are clearly visible. Nuclei were counterstained with Hoechst.
Scale bars, 100mm. (E) RT-qPCR analyses showed that skeletal muscle-specific ryanodin receptor (RyR1) mRNA is expressed
by twitching myotubes, although at lower levels than skeletal muscle (SkM)-positive control. (E, F) The absence of cardiac-
specific RyR2 mRNA (E, as compared with positive cardiac muscle-CdM control) and cardiac-specific troponin (TNNI-3)
expression by WB (F), corroborated the skeletal (not cardiac) nature of contractile myotubes. Color images available online at
www.liebertpub.com/tec
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confirmed that muscle tissue remnants appeared in dermal
cultures at day 0, but not at day 7, and suggested the ap-
pearance/enrichment of a myogenic precursor during pro-
liferation culture. To further validate protein expression data,
messenger RNA levels for the genes Pax7, MyoD1, Myog,
MyH2 (adult myosin), and MyH3 (embryonic myosin) were
analyzed at day 7 relative to day 0 by real-time quantitative
PCR (RT-qPCR, Fig. 2C). The results confirmed a reduction of
myogenic gene mRNA levels as culture progressed, with the
exception of embryonic MyHC that was stable or augmented
with culture progression. To discriminate the proportion of
sphere cells adopting myogenic commitment, expression of
MyoD1, Myog, MyHC, TnT, and Serca1 was analyzed by
immunofluorescence in day 7 dermospheres (Fig. 2D).
FIG. 4. Ultrastructural
characterization of myotubes.
(A–C). Aspect of semithin
(1.5-mm) sections stained with
Toluidine blue. (A) Semithin
sections showing tubular and
spherical cells (scale bar,
100mm). (B) Longitudinally
oriented myofibers show
clear striations (scale bar,
40mm). (C) A transversally
sectioned fiber sits on top of a
longitudinally sectioned fiber
(scale bar, 30mm). (D–H) Ul-
trathin (70-nm) sections of
muscle fibers, as seen by
electron microscopy. (D) Pa-
noramic view of two adjacent
cells (separated by a discon-
tinuous line), where typical
striations of skeletal muscle
may be seen. Position of A
band, I band, and Z line are
indicated (scale bar, 2 mm).
Enlarged mitocondria run-
ning parallel to fibers are also
visible. (E) Enlarged image of
myofiber organization.
Smooth endoplasmic reticu-
lum (SER) cisternae and mi-
tocondria are alternatively
detected between myofiber
groups (scale bar, 1mm). (F)
Transversal section, where
myofiber organization is ob-
served: myofibrils are sur-
rounded by SER (arrows) and
mitochondria (scale bar,
500 nm). (G) Dense muscular
(adherens) junctions (arrows)
in between adjacent muscular
fibers (scale bar, 200 nm). (H)
Two transversally sectioned
myofibers show abundant
caveoles (arrows) in the
proximity of the cell mem-
brane and myofibrils (scale
bar, 500 nm). Color images
available online at www
.liebertpub.com/tec
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Interestingly, a discrete subpopulation of cells was found to
express myogenic markers, while the bulk of the precursor
cells in the sphere remained negative at day 7. Taken together,
these results suggest that twitching myotubes derive from a
discrete population of myogenic precursors present in dermal
spheres at day 7 of proliferation.
Myotubes present structural characteristics
of bona fide skeletal muscle
To further characterize in vitro engineered myotubes, the
expression and subcellular localization of myogenin and
MyHC were analyzed by immunofluorescence (Fig. 3). As
expected, multinucleated myotubes that express nuclear
Myog were readily detected (Fig. 3A, B). Myotubes showed
the characteristic striated pattern of MyHC, as predicted for
sarcomeric proteins (Fig. 3C, D). Since SKPs are neural crest
derived, and similar tissue-resident precursors have been
shown to differentiate into cardiomyocites,29 we wondered if
the observed striated phenotype might correspond to the
cardiac, not skeletal muscle. For this reason, we analyzed
expression of skeletal or cardiac muscle-specific ryanodine
receptors by RT-qPCR (Fig. 3E). Skeletal muscle-specific
RyR1 mRNA was readily detected, while cardiac muscle-
specific RyR2 remained undetectable as compared to control
samples of both striated muscles. Cardiac-specific TNNI-3
was also absent from engineered myotube cultures, as as-
sessed by Western blot (Fig. 3F).
FIG. 5. Acetylcholine-elicited currents (IACh) and electrical excitability of differentiated beating myotubes. (A) Example
nicotinic current (IAch) traces obtained under the voltage-clamp mode of the patch-clamp technique in the presence of Ca
2 +
and Na + (Ctrl), in the absence of Ca2 + (Ca2 + free), and in the absence of Ca2 + and Na + (Ca2 +/Na+ free). (B) Quantitative
pooled results on the effects of Na + and Ca2 + removal on IACh, and current recovery on returning to the control extracellular
saline solution (W/O). (C) A current-clamped myotube that exhibited spontaneous firing of action potentials that were
suppressed by tetrodotoxin (TTX). (D) Effects of the d-tubocurarine (dTC) cell perifused 5min before and during the ACh
pulse; peak current (I) and charge (Q) were normalized in each individual cell expressed as% of initial ACh pulse. Data in
panels B andD are means – SEM. of the number of cells (n) from different cultures (N) shown in parentheses (n, N). **p< 0.01,
***p< 0.001, with respect to controls.
FIG. 6. Characterization of cytosolic Ca2 + transients elicited by challenging myotubes with various stimuli. Cells were
loaded with the calcium probe Fura-2 AM and were subsequently perifused with various saline solutions containing different
stimulating compounds. (A) The time course of a cytosolic calcium transient is shown as a sequence of photograms taken
from the time points shown in the kinetic trace in the middle panel. (B) Cytosolic Ca2 + transients elicited by acetylcholine
(ACh), nicotine (Nic), histamine, and caffeine (Caf) sequentially applied to a perifused example beating myotube. (D)
Example cell that only responded to histamine. (C and E) Bar diagrams showing statistically significant differences between
the various stimuli. This pattern of stimuli could be used to differentiate between muscle and other types of responsive cells.
(F)Nifedipine (Nif) present before and during the second stimulus, did not affect the [Ca2 + ]c transient elicited by ACh. (G) In
contrast, the neuromuscular alkaloid blocker d-tubocurarine (dTC) was able to mitigate the Ca2 + entry elicited by nicotinic
receptor stimulation with ACh. Data in panels C, E, F, and G are shown as mean– SEM. of the number of cells (n) from
different cultures (N), shown in parentheses. *p < 0.05, ***p < 0.001, with respect to the control pulses of 100 mMACh (one-way
ANOVA and Dunnett’s post hoc test). Color images available online at www.liebertpub.com/tec
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Ultrastructural analyses were then performed by trans-
mission electron microscopy (TEM) (Fig. 4). Semithin (1.5-
mm) sections of resin-embedded tissue constructs showed
cells of either spherical or elongated morphology (Fig. 4A).
Spherical cells typically were found with irregularly shaped
multiple nuclei that were centrally positioned and abundant
organelles scattered through the cytoplasm, with frequent
detection of small vacuoles. Some of the spherical cells had a
smaller size, irregular cell shape, scarce cytoplasm, and very
dense nuclei (not shown). In contrast, elongated cells (Fig.
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4B) were tubular as clearly visualized on transversal sections
(Fig. 4C). Elongated (tubular) cells presented no expansions
in contrast to spherical cells. Tubular cells showed a number
of centrally positioned nuclei, each having several nucleoli.
Interestingly, some elongated cells showed striation of dense
and light bands (Fig. 4B). By TEM, the classical actomyosin
structures characteristic of striated muscle were clearly visi-
ble (A- and I-bands; H zone and Z-line in the sarcomeres;
Fig. 4D, E). Repeated measurements showed that sarcomeres
were 1.5–3.3 mm long, A-bands 1–2mm, and I-bands 0.5–
1.3 mm. Overall, actomyosin fibers were 0.3–0.6mm thick.
Prolonged mitochondria running parallel to the fibers were
often visible; some of them were branched, with abundant
crests (Fig. 4D, E), and were also aligned to smooth endo-
plasmic reticulum (SER). Besides, SER cisternae surrounded
actin and myosin bundles in transversal sections (Fig. 4F), as
well as transversally oriented mitochondria. Golgi bodies
scattered throughout the cytoplasm were also found. Un-
striated fusiform cells, which presented abundant dilated
rough endoplasmic reticulum (RER) cisternae, were identi-
fied as possible fibroblasts. In contrast, striated muscular
cells presented scarce, generally undilated RER. Muscle fi-
bers showed no branching and occasionally adherens junc-
tions were seen between adjacent cells (Fig. 4G). Abundant
caveolae were seen on the cell surface in transversal sections
(Fig. 4H). These results unequivocally demonstrate that
skeletal (not cardiac) muscle-like myotubes are being en-
gineered in vitro that fully recapitulate ultrastructural char-
acteristics of bona fide skeletal muscle.
Electrophysiological characterization of in vitro
engineered myotubes
Once characterized by immunocytochemistry and specific
biomarkers, we pursued functional studies to determine the
nature of the cells under study. Electrophysiological experi-
ments were performed by patching dermis-derived myo-
tubes and challenging them with 100 mM ACh pulses of
250ms duration (Fig. 5). ACh evoked a 2 nA inward current
when membrane potential was clamped at - 80mV. After
rapid activation kinetics, slow inactivation developed lasting
for about 5 s (Fig. 5A). ACh current charge (QACh) were
carried by Na + and Ca2 + ions, so its substitution by the same
mOsm quantity of N-metyl-D-glucamine resulted in a strong
reduction in QACh and IACh peak (Fig. 5B). In current clamp
configuration, a twitching myotube fired spontaneous action
potentials that were abolished in the presence of the Na +
channel blocker TTX (Fig. 5C). To further characterize the
nature of the receptor implicated in this signal, we tested the
neuromuscular blocker d-tubocurarine in our preparation.
At 10 mM, this drug reversibly blocked IACh and QACh by 90%
approximately (Fig. 5D).
Muscle contraction is a Ca2 + -dependent process, which in
turn depends on cell depolarization and Ca2 + -induced Ca2 +
release (CICR) from the sarcoplasmic reticulum.30 So, we
wanted to look at cytosolic Ca2 + signaling ([Ca2 + ]c) medi-
ated by ACh receptor stimulation (Fig. 6). Cells were incu-
bated for 1 h with Fura-2AM. Under fluorescence recording,
cells stimulated with ACh increased their [Ca2 + ]c as shown
in Figure 6A and Supplementary Movie SM4. Each photo-
gram is taken at different time points after application of the
100 mM ACh pulse. These cells were tested against other
stimuli, namely, nicotine, caffeine, and histamine. Twitching
cells responded to 30mM nicotine, 20mM caffeine, but not to
100 mM histamine (Fig. 6B, C and Supplementary Table S1).
However, another cell population with different morphology
(not myotubes), also present in dermis-derived muscle cul-
tures, had the opposite response pattern increasing their
[Ca2 + ]c in response to histamine, but not to caffeine or nic-
otine (Fig. 6D, E and Supplementary Table S1). At this time
FIG. 7. ECM-based differentiation cultures show enhanced myogenicity. In parallel differentiation cultures run for 12 days,
ECM-based cultures were compared to 5-azacytidine-based counterparts.16 (A) RT-qPCR analyses were performed for Pax7,
MyoD1, Myog, MyH2, and MyH3 mRNAs. (B–D) Immunofluorescence analyses were performed for myogenin (B, C) and
MyHC (D). Scale bars, 100 mm. Color images available online at www.liebertpub.com/tec
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point, the question of whether the observed [Ca2 + ]c increase
was a dihydropirydine-dependent effect arose. So, we mea-
sured ACh-mediated [Ca2 + ]c in the presence of 3mM nifed-
ipine and congruently found that calcium peak amplitudes
were unaffected by nifedipine incubation (Fig. 6F and Sup-
plementary Table S2). In contrast, 10mM d-tubocurarine
significantly blocked the ACh-induced [Ca2+ ]c increase (Fig.
6G and Supplementary Table S3). These results demon-
strated that beating myotubes exhibited characteristics
compatible with a skeletal muscle fiber nature, namely, (1)
d-tubocurarine-sensitive and Na + - dependent inward cur-
rents generated by the muscle end plate physiological neu-
rotransmitter ACh, (2) ACh-elicited cytosolic Ca2+ transients
that are also blocked by d-tubocurarine, and (3) caffeine-
elicited [Ca2+ ]c transients compatible with sarcoplasmic
reticula Ca2+ release mediated by RyR1 receptors.
Myogenicity of ECM-based cultures as compared
to previous differentiation protocols
Although several reports have addressed myogenicity of
dermal cells, quantitative data are often lacking. Due to the
impressive, widespread contractility observed on ECM-
based cultures, we were interested in performing a quanti-
tative comparison with previously published differentiation
protocols. To this end, we chose the protocol based on the
use of 5-azacytidine as an inducer of myogenic differentia-
tion.16 Parallel differentiation cultures were set up and direct
comparison was performed by RT-qPCR and immunofluo-
rescence analyses (at day 1 vs. day 12 of differentiation,
Figure 7). As expected, mRNAs for Pax7, MyoD1, Myog,
MyH2, and MyH3 were clearly overexpressed in ECM-based
cultures as compared to 5-azacytidine-based cultures (Fig.
7A). Immunofluorescence analyses demonstrated a major
increase in MyHC( + ) myotubes when the ECM was used as
a substrate, although there was no significant difference on
Myog levels (Fig. 7B–D). These results pointed to a faster
generation of dermis-derived myotubes on the ECM as
compared to 5-azacytidine-based cultures.
Long-term evolution of ECM-based cultures
While satellite cell-derived myotubes grown on Matrigel
show great resilience in vitro,18 we observed that ECM-based,
dermis-derived cultures, which were derived from complex
cellular mixtures, degraded over time (Fig. 8). To character-
ize this phenomenon, we investigated expression of myo-
genic mRNAs Myog and MyH2 over a 28-day period of
differentiation. Interestingly, myogenin peaked at day 7,
while adult myosin expression levels reached their highest at
day 14, both of them decreasing sharply afterward (Fig. 8A).
Of note, muscle degeneration is concomitant with fatty
FIG. 8. Long-term progression of myotube cultures shows fatty infiltration. (A) Gene expression analyses by RT-qPCR
revealed an early expression of myogenic mRNAs (Myog andMyH2; peaking at 7–14 days), followed by a clear decrease after
20 days of differentiation. Concomitantly, an increased expression of adipogenic genes PPARc, AdipoQ, and FABP4 was
detected peaking at day 14–21. (B, C) A progressive differentiation of adipocytes was visible by Oil Red O staining (B, · 100),
peaking after 21 days in culture (C). (D) The triglyceride content confirmed these data. (E) The aged appearance of engineered
skeletal muscle after 1 month in culture is shown. Note that the ECM is progressively peeling off the edges of the culture plate
due to the force generated during the contractions of myotubes. The abundance of adipocytes makes the aged culture turn
yellow. Color images available online at www.liebertpub.com/tec
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infiltration in vivo, and a PDGFRa + precursor cell popula-
tion, which resides in muscle, but is distinct from satellite
cells, seems to be responsible for this phenomenon.31 For
these reasons, we checked PPARc, AdipoQ, and FABP4 adi-
pogenic gene expression during the same time frame. Strik-
ingly, adipogenic genes peaked at day 14 to 21, concomitant
with loss of myogenic gene expression (Fig. 8A). Accord-
ingly, adipocytes were visible by Oil Red O staining by day
7, and abundantly so after day 21 (Fig. 8B). Adipocytes
matured in culture over time, with increased fusion of cy-
toplasmic lipid vesicles. Moreover, quantitative analyses of
Oil Red O and trygliceride content showed a sustained in-
crease in culture over time (Fig. 8C, D). In summary, these
results are consistent with degradation of the muscle con-
structs in vitro (Fig. 8E) that is coincident in time with the
appearance of fat tissue.
Discussion
In this study, we improved previously published proto-
cols to engineer the skeletal muscle from dermal precursor
cells.16,17 Underlying this improvement in muscle quantity
and quality (at least in vitro), the use of a Matrigel-like
platform might have been critical.32 Muscle organoids have
been previously derived from primary neonatal rodent
myoblasts suspended in a 1:6 solution of Matrigel: Collagen
type I.33 However, several issues remain unresolved.
For a start, the nature and origin of the discrete population
of myogenic precursor cells present in primary dermo-
spheres is still unclear. We have shown that Panniculus car-
nosus (PC), a vestigial muscle in mammals that is often
neglected by the literature,17 is present in murine dermal cell
preparations. PC muscle derives from Pax7 + cells, as dem-
onstrated when these progenitors were genetically traced
both at the E9.5 (multipotent stem cells of the dermomyo-
tome) and E11.5 (cells restricted to the myogenic lineage)
developmental stages.34 On the other hand, skeletal muscle
regeneration consists of the fusion of myoblasts for de novo
myotube formation, generated not only by satellite cells, but
also by a number of other cell types such as bone marrow-
derived mesenchymal stromal cells, muscle side population
cells, and pericytes.35 In murine models, PC has been shown
to possess a higher regenerative activity than most skeletal
muscles, with significantly smaller fiber diameters, increased
heterogeneity of the fiber size, and a high percentage of
centrally nucleated myofibers in the absence of focal injury.
Further, PC myofibers present the highest rate of bone
marrow-derived cell incorporation.36 An enticing possibility
that requires further investigation is that the myogenic pre-
cursors in PC originate in the bone marrow, and that bone
marrow-derived cells underlie the phenomena observed
when dermospheres were put under myogenic stimulation.
A second question that remains unanswered is the origin
of the fatty infiltration that we observed. Adipogenic differ-
entiation is detected in isolated myofibers, suggesting that
satellite cells or other progenitors that reside in that same
niche contribute to fat formation.37 Furthermore, the exis-
tence of fibro/adipogenic progenitors (FAP) in vivo, which
are perivascular localized and distinct from satellite cells, has
been postulated.31 It is therefore plausible that such FAPs
might also be present in other interstitial tissues such as the
dermis, although PPAR and FABP detection may not directly
reflect the presence of FAPs, but truly relate to fatty infil-
tration. Since an intact niche is key to the maintenance of the
satellite stem cell pool,38 an attractive hypothesis would be
that ECM degradation provoked by myotube maturation
could alter the balance of the transition from myogenesis to
adipogenesis.39 However, experimental evidence for this
proposal is currently lacking. In any case, the engineered
muscle system presented here represents a major improve-
ment over modeling systems where muscle ageing is mim-
icked by making use of high passage myoblast cell lines.40
The generalized contractile phenotype we observed was
highly reminiscent of that described for chicken myogenic
cultures grown on Matrigel, in the absence of innervation.18
In contrast, human myotubes in monolayer culture present
sparse spontaneous contractions that may be improved by
motor neuron innervation.41 For this reason, cocultures of
spinal cord explants with myofibers have long been per-
formed to achieve functional innervation and contractile
behavior.42 More recently, neuromuscular junctions have
been engineered in vitro from human ESC-derived cocul-
tures.43,44 Given the fact that the very same ECM/dermal
precursor combination we used in this article has been
shown to efficiently generate neural progeny,20,21 the fol-
lowing question arose: are in vitro engineered myotubes in-
nervated by motor neurons present in dermis-derived
cultures? The most plausible answer is no, since no neurons
were present in the original dermal cell starting culture and
myotube contractions are visible very early, only a few days
after differentiation starts. On the other hand, we detected
nicotinic ACh receptor (nAChR) clusters on myotubes
(Supplementary Fig. S2), reminiscent of those seen in neu-
romuscular junctions; in fact, stimulation of these receptors
with ACh generates inward ACh currents and [Ca2 + ]c sig-
nals very similar to those found in control skeletal muscle.30
However, clusters of nAChR are present in extrajunctional
areas of tissue-cultured embryonic muscle.45 Furthermore,
prepatterned nAChR clusters are known to be required for
twitching of developing myotubes, through autocrine acti-
vation.46,47 Alternatively, non-neuronal cells present in the
dermis could be the source of ACh in these cultures.48
Ideally, the engineered muscle of human (not murine)
origin should be employed to test novel therapeutics. It
might follow that, since SKPs are also present in human
beings, engineered human muscle could also be produced in
a similar fashion. Our data suggest that myogenic precursors
are present early after isolation, possibly related with the
existence of muscle fragments in the original disaggregated
cell mixture. These myogenic precursors could thus originate
in the PC, a vestigial organ in humans. Although further
research is needed to ascertain this point, if muscle-derived
progenitors are eventually required for this process, then
human skin should be obtained from the limited areas of the
body that present this vestigial muscle.49 First of all, mouse
lineage-tracing experiments should be performed that shed
further light on the cell lineage originating dermis-derived
muscle. Secondly, if PC-derived myogenic precursors are
traced in the murine models, a confirmation of mouse data
should be obtained by using human PC-derived cells. This
might prove difficult because of limited PC availability in the
human body and the necessity to perform full-thickness skin
biopsy that reaches up to the fascia. A promising approach
might be isolation of stem cells from human cadavers as
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recently reported.50 Independently of the potential difficul-
ties in extending this model to human cells, we present a
robust model, genetically unmodified, that may be of use to
model a number of muscular diseases using genetically
modified mice as a source of skin cells. Furthermore, the
unique ability to model fatty infiltration as seen after natural
muscle atrophy should be of great use to test novel phar-
macological approaches to age-related fragility.
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